|
Mechanism5-HT2 receptor antagonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with MTNR1A x 5-HT2 receptor
100 Translational Medicine associated with MTNR1A x 5-HT2 receptor
0 Patents (Medical) associated with MTNR1A x 5-HT2 receptor